Nestle, Kellogg, General Mills, Unilever among major U.S. food manufacturing companies being accused of infringing patents covering fats that alter ratio of 'good' and 'bad' cholesterol in blood

Nevin Barich

Nevin Barich

LOS ANGELES , March 5, 2012 () – Brandeis University and GFA Brands are accusing such major U.S. food manufacturing companies as Nestle, Kellogg, General Mills and Unilever of infringing patents covering fats that alter the ratio of “good” and “bad” cholesterol in the blood, NutraIngredients-USA reported March 5.

Brandeis and GFA allege that these companies and others infringed upon U.S. patents that was awarded to Brandeis and licensed exclusively to GFA. The patents cover fats and fat blends that decrease bad LDL cholesterol and increase good HDL cholesterol in the human serum.

The plaintiffs, who are seeking a jury trial and damages, allege that the defendants have made, sold or imported products that infringe the patents, or bought fats that infringe the patents and used them in the manufacturing of their products. The defendants, meanwhile, claim that the lawsuit is without merit.

The primary source of this article is NutraIngredients-USA, Montpellier, France, on March 5, 2012.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

Share:

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.